PharmacistNCT03223584
Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge
An observational study of Pharmacist and Physicians, Primary Care, run by KU Leuven at 1 site in Belgium.
Trial summary
Title of the research: Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge Study area: Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group). Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Pharmacist, Physicians, Primary Care, Patient Discharge
- How many people
- 30 participants
- Where
- 1 siteBelgium
- Study dates
- Nov 2015to Apr 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.
Who may be able to join
- Profession: general practitioner or community pharmacists
- Employment in care regions Leuven, Bruges or Kontich
- Experience in daily practice
- Interest in research or optimisation of the healthcare profession. For example supervisors of an internship, local coordinators of general practitioners or pharmacy clusters and active HCP that are linked with professional associations.
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
Title of the research:
Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge
Read more
Study area:
Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group).
Aims:
From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document.
Study design:
A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group.
Study population:
Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.
Number of health care professionals:
Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel.
Procedures:
Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.
- Conditions
- Pharmacist, Physicians, Primary Care, Patient Discharge
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Pharmacists-Leuven | Individual interviews with approximately 5 pharmacists | |
| Pharmacists-Bruges | Individual interviews with approximately 5 pharmacists | |
| Pharmacists-Mortsel | A focus group with pharmacists and general practitioners | |
| General Practitioners-Leuven | Individual interviews with approximately 5 general practitioners | |
| General Practitioners-Bruges | Individual interviews with approximately 5 general practitioners | |
| General Practitioners-Mortsel | A focus group with pharmacists and general practitioners |
What is being measured
The primary outcome is the main question the study is designed to answer.
Semi-structured interviews/focus group: Experienced problems and solutions
Experienced problems during counseling of discharged older patients and potential solutions
Measured: Approximately 1 hour
Semi-structured interviews: Strengths and weaknesses of a proposal for a discharge document for community pharmacist (using open ended questions)
During the interviews, a proposal for a discharge document will be shown to healthcare professionals. They will be asked to give their feedback on the content of the document (not applicable for the focus group)
Measured: Approximately 1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jul 2017
- Study startNov 2015
- Primary completionApr 2016
- Study completionApr 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PharmacistStudies of the same condition, open and under way.
- More trials run by KU LeuvenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- KU Leuven
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Joke Wuyts, KU Leuven
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03223584
- Sponsor's protocol ID
- S58480
- Status last verified
- Feb 2018
- First submitted
- 25 Jan 2016
- Last updated
- 13 Feb 2018
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Wuyts J, Vande Ginste M, De Lepeleire J, Foulon V. Discharge report for the community pharmacist: Development and validation of a prototype. Res Social Adm Pharm. 2020 Feb;16(2):168-177. doi: 10.1016/j.sapharm.2019.04.049. Epub 2019 Apr 25.
PubMed 31078447
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge
- ClinicalTrials.gov ID
- NCT03223584
- Acronym / sponsor ID
- S58480
- Conditions
- Pharmacist, Physicians, Primary Care, Patient Discharge
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- KU LeuvenUniversity, hospital or other
- Study start
- Nov 2015
- Primary completion
- Apr 2016 (actual)
- Study completion
- Apr 2016 (actual)
- First posted
- 21 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Title of the research:
Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge
Study area:
Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group).
Aims:
From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document.
Study design:
A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group.
Study population:
Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.
Number of health care professionals:
Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel.
Procedures:
Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Pharmacists-Leuven | – | –Individual interviews with approximately 5 pharmacists |
| Pharmacists-Bruges | – | –Individual interviews with approximately 5 pharmacists |
| Pharmacists-Mortsel | – | –A focus group with pharmacists and general practitioners |
| General Practitioners-Leuven | – | –Individual interviews with approximately 5 general practitioners |
| General Practitioners-Bruges | – | –Individual interviews with approximately 5 general practitioners |
| General Practitioners-Mortsel | – | –A focus group with pharmacists and general practitioners |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.
Key inclusion criteria (4 listed)
- Profession: general practitioner or community pharmacists
- Employment in care regions Leuven, Bruges or Kontich
- Experience in daily practice
- Interest in research or optimisation of the healthcare profession. For example supervisors of an internship, local coordinators of general practitioners or pharmacy clusters and active HCP that are linked with professional associations.
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Semi-structured interviews/focus group: Experienced problems and solutions
Time frame: Approximately 1 hour
Experienced problems during counseling of discharged older patients and potential solutions
Semi-structured interviews: Strengths and weaknesses of a proposal for a discharge document for community pharmacist (using open ended questions)
Time frame: Approximately 1 hour
During the interviews, a proposal for a discharge document will be shown to healthcare professionals. They will be asked to give their feedback on the content of the document (not applicable for the focus group)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2018.
- Derived from this study: PubMed 31078447Wuyts J, Vande Ginste M, De Lepeleire J, Foulon V. Discharge report for the community pharmacist: Development and validation of a prototype. Res Social Adm Pharm. 2020 Feb;16(2):168-177. doi: 10.1016/j.sapharm.2019.04.049. Epub 2019 Apr 25.
- Individual participant dataSharing planned: No
Related trials for Pharmacist
Not yet recruiting
Impact of Pharmaceutical Intervention in Self-Medication: Focus on Pain Management in Pharmacies
Self-medication for Pain, Limits on Advice From Community Pharmacists and Referral to a Primary Care Practitioner
Active, not recruiting
Healthy Opioid Prescription Engagement
Opioid Misuse, Opioid-Related Disorders
Not yet recruitingObservational study
MOving Forward With MENopause Treatment Through Pharmacists' Expanded Roles in Hormone Health
Menopause, Pharmacists
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pharmacist and Physicians, Primary Care, run by KU Leuven at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Semi-structured interviews/focus group: Experienced problems and solutions (time frame: Approximately 1 hour). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03223584, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2018; AzTrials last refreshed its copy on 2 Nov 2026.